Studies in advanced chronic liver disease
21-10-2020, R.C. Oey
Optimizing treatment strategies in autoimmune hepatitis
16-10-2020, S. Pape
Transplantation of High Risk Donor Livers Machine Perfusion Studies To Improve and Predict Post Transplant Hepatobiliary Function
14-10-2020, Y. de Vries
Predicting outcomes and personalizing treatment in hepatocellular carcinoma
30-9-2020, T. Labeur
Liver health in the general population: the role of diet, body composition and the gut microbiome
25-9-2020, L. Alferink
The role of the gaseous signaling molecule hydrogen sul-fide in chronic liver disease with Special emphasis on non-alcoholic fatty liver disease
7-9-2020, T. Damba
Fibrosing cholangiopathies: Insights in clinical aspects and novel therapeutic approaches
30-6-2020, E.S. de Vries
Molecular insight into the bile acid transporter NTCP
7-5-2020, M. Appelman
Decoding therapeutic roles of adipose tissue-derived stromal cells and their extracellular vesi-cles in liver disease
6-4-2020, D.A. Afsharzadeh
Prognosis and Treatment of Primary Biliary Cholangitis – a new name, a new era
10-1-2020, M.H. Harms